An early analysis based on 168 patients with severe COVID-19 demonstrated differences in male and female laboratory parameters, including neutrophil/lymphocyte ratios (NLR), C-reactive protein (CRP), ferritin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen, and creatinine levels [5]. The gene discussed is GPT; the disease is COVID-19.